Literature DB >> 2533500

Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha.

S Grenfell1, N Smithers, K Miller, R Solari.   

Abstract

In this study we demonstrate that 125I-labelled interleukin (IL) 1 alpha binds specifically to its receptor on the surface of EL4 6.1 cells and is subsequently endocytosed and translocated from the cell membrane to the nucleus, where it progressively accumulates. Two-dimensional polyacrylamide-gel electrophoresis revealed that the internalized 125I-IL1 alpha associated with the nucleus was intact, with negligible breakdown products present. Specific and saturable binding of 125I-IL1 alpha was demonstrated on purified nuclei isolated from these cells. Binding of the radiolabelled ligand showed similar kinetics to that of the plasma-membrane receptor, and was inhibited by both unlabelled IL1 alpha and IL1 beta. Equilibrium binding studies on isolated nuclei revealed a single high-affinity binding site, with a Kd of 17 +/- 2 pM, and 79 +/- 12 binding sites per nucleus. These studies demonstrate that receptor-mediated endocytosis of IL1 results in its accumulation in the nucleus, and this mechanism may play an important role in mediating some of the actions of IL1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533500      PMCID: PMC1133658          DOI: 10.1042/bj2640813

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  60 in total

1.  Factors affecting the reproducibility of a spectrofluorimetric assay for the enumeration of human venous endothelium in culture.

Authors:  G Mates; M Daniel; C Walker
Journal:  Cell Biol Int Rep       Date:  1986-08

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Studies on the fate of receptor-bound 125I-interleukin 1 beta in porcine synovial fibroblasts.

Authors:  T A Bird; J Saklatvala
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

5.  Isolation of nuclei from liver and other tissues.

Authors:  J R Tata
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

6.  Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).

Authors:  P R Salacinski; C McLean; J E Sykes; V V Clement-Jones; P J Lowry
Journal:  Anal Biochem       Date:  1981-10       Impact factor: 3.365

7.  Nerve growth factor in the nucleus: interaction with receptors on the nuclear membrane.

Authors:  B A Yankner; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: evidence for potential intracellular sites of insulin action.

Authors:  I D Goldfine; G J Smith; K Y Wong; A L Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

9.  Nuclear accumulation of epidermal growth factor in cultured rat pituitary cells.

Authors:  L K Johnson; I Vlodavsky; J D Baxter; D Gospodarowicz
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

10.  Cell surface distribution and intracellular fate of asialoglycoproteins: a morphological and biochemical study of isolated rat hepatocytes and monolayer cultures.

Authors:  P L Zeitlin; A L Hubbard
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

View more
  11 in total

1.  Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Authors:  K L A Souza; M Elsner; P C F Mathias; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

2.  cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium.

Authors:  S Haskill; G Martin; L Van Le; J Morris; A Peace; C F Bigler; G J Jaffe; C Hammerberg; S A Sporn; S Fong
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein.

Authors:  F T Stevenson; J Turck; R M Locksley; D H Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies.

Authors:  M H Foster; T Kieber-Emmons; M Ohliger; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 5.  Cellular signalling mechanisms in B lymphocytes.

Authors:  W Cushley; M M Harnett
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

6.  Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis.

Authors:  L N Heiss; S A Moser; E R Unanue; W E Goldman
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Interleukin-1 receptor antagonist in normal and psoriatic epidermis.

Authors:  C Hammerberg; W P Arend; G J Fisher; L S Chan; A E Berger; J S Haskill; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells.

Authors:  J A Maier; M Statuto; G Ragnotti
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

9.  Analysis of mutations in the putative nuclear localization sequence of interleukin-1 beta.

Authors:  S Grenfell; N Smithers; S Witham; A Shaw; P Graber; R Solari
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

Review 10.  Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy.

Authors:  N M Luheshi; N J Rothwell; D Brough
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.